Related Experiment Video
Updated: May 11, 2026
11:23
A Multilayer Microfluidic Platform for the Conduction of Prolonged Cell-Free Gene Expression
Published on: October 6, 2019
In vitro regulatory models for systems biology
Anthony J Genot1, Teruo Fujii, Yannick Rondelez
1LIMMS/CNRS-IIS, Institute of Industrial Science, The University of Tokyo, 4-6-1 Komaba, Meguro-ku, Tokyo 153-8505, Japan.
Biotechnology Advances
|May 8, 2013
Summary
Scientists are building artificial biochemical networks to understand complex cellular interactions. These synthetic biological systems mimic genetic regulation, leading to insights into cellular networks and disease.
Area of Science:
- Systems biology
- Synthetic biology
- Biochemistry
Background:
- The reductionist approach has limitations in explaining complex cellular interactions revealed by high-throughput technologies.
- Understanding the deluge of 'omic data' requires a hypothesis-driven approach to decipher biomolecular interactions.
- Cellular networks are complex systems where interactions shape function.
Purpose of the Study:
- To review efforts in constructing in vitro biochemical networks that mimic genetic regulation.
- To highlight the rational design of synthetic biochemical oscillators and bistable memory devices.
- To extract key principles from in vitro systems applicable to in vivo cellular circuits.
Main Methods:
- Review of recent literature on in vitro biochemical network construction.
- Analysis of synthetic biological systems like oscillators and memory devices.
- Comparative study of in vitro networks with in vivo cellular circuits and ecosystems.
Main Results:
- Successful rational construction of in vitro biochemical oscillators and bistable memories.
- Demonstration of in vitro systems reproducing aspects of genetic regulation.
- Identification of critical factors in biological circuits, including delays, competition, topology-kinetics links, and network-ecosystem resemblances.
Conclusions:
- In vitro biochemical networks provide powerful models for understanding complex cellular systems.
- Synthetic biology approaches are crucial for deciphering genetic regulation and network dynamics.
- Lessons learned from synthetic circuits offer insights into biological complexity, network design principles, and the organization of life.
Related Concept Videos
01:14Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model
The link model is a fundamental pharmacokinetic-pharmacodynamic (PK–PD) approach to account for delayed drug responses when the observed effect does not immediately correlate with the drug's plasma concentration peak. This delay is mathematically addressed by introducing an effect compartment concentration, Ce, which is kinetically linked to the plasma concentration, Cp, via a first-order rate constant, ke0. The linkage allows for a more accurate prediction of drug effects over time. A higher...
01:26Pharmacokinetic Models: Comparison and Selection Criterion
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
01:20Pharmacokinetic Models: Overview
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:27Pharmacodynamic Models: Overview
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
01:28Global Regulatory Systems
Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...